Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
07/1997
07/16/1997EP0728132B1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives
07/16/1997EP0717751B1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t
07/16/1997EP0586618B1 The use of nucleic acid analogues in diagnostics and analytical procedures
07/16/1997CN1154704A New peptides with immunomodulatory effect
07/16/1997CN1154365A Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products
07/15/1997US5648511 Method for making intermediates useful in the synthesis of retroviral protease inhibitors
07/15/1997US5648497 Retroviral protease inhibiting compounds
07/15/1997US5648470 Phenylboronic acid complexing reagents derived from aminosalicyclic acid
07/15/1997US5648393 Treatment of male impotence with s-nitrosylated compounds
07/15/1997US5648364 Heterocyclic peptide compounds as enzyme inhibitors
07/15/1997US5648338 Inhibitors and substrates of thrombin
07/15/1997US5648337 Antiherpes pentapeptides
07/15/1997CA2063400C Inhibition of the n-end rule pathway in living cells
07/10/1997WO1997024369A1 Growth-hormone secretagogues
07/10/1997WO1997024339A1 Tetrazole derivatives and drugs containing the same as the active ingredient
07/10/1997WO1997012850A3 Bifunctional, sulphide-containing sulphonamide-chelating agents of xsny type for radioactive isotopes
07/09/1997EP0783002A2 Dual action inhibitors
07/09/1997EP0782580A1 Parallel selex
07/09/1997CN1154114A New thrombin inhibitors, their preparation and use
07/09/1997CN1153784A Biotin derivatives
07/08/1997US5646276 Angiotensin converting enzyme and neutral endopeptidase inhibitors; cardiovascular disorders
07/08/1997US5646272 Bile acid conjugates of proline hydroxylase inhibitors
07/08/1997US5646177 Glutathione derivatives of anthracyclines
07/08/1997US5646165 Methionine sulfone and S-substituted cysteine sulfone derivatives as enzyme inhibitors
07/08/1997US5646140 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
07/08/1997US5646121 Pseudopeptides with antiviral activity
07/08/1997US5645837 Drugs to inhibit rejection of organ rejection after grafting; bone marrow grafting
07/08/1997US5645815 Radiolabled compounds for thrombus imaging
07/08/1997CA2057913C N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
07/03/1997WO1997023508A1 Compounds with growth hormone releasing properties
07/03/1997WO1997023499A1 Prodrugs of thrombin inhibitors
07/03/1997CA2239711A1 Compounds with growth hormone releasing properties
07/03/1997CA2238737A1 Prodrugs of thrombin inhibitors
07/02/1997EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
07/02/1997EP0781124A1 Active agent transport systems
07/01/1997US5644055 Cyclization of indole or quinoline compound, enzyme inhibitors, treatment of cardiovasacular disorders
07/01/1997US5644025 Tetrapeptides deriving from dalbaheptide antibiotics
07/01/1997US5644024 Tetrahydronaphthalene derivatives
07/01/1997US5643957 Compounds and compositions for delivering active agents
07/01/1997US5643924 Retroviral protease inhibitors
07/01/1997US5643904 Treating pain, ulcers, collitis, anxiety and panic disorder
07/01/1997US5643879 Oligopeptide enzyme inhibitors as hypotensive agents
07/01/1997US5643878 Treatment of retroviral diseases like aids
07/01/1997US5643872 Antiagglomerants for platelets, anticoagulants
07/01/1997US5643871 Antitumor antibiotics
06/1997
06/26/1997WO1997022712A1 NOVEL PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-β-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH¿2?
06/26/1997WO1997022620A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
06/26/1997WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/26/1997WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/26/1997WO1997022367A1 Radiolabeled growth hormone secretagogue
06/26/1997CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme
06/25/1997EP0779815A1 Surface-modifying copolymers having cell adhesion properties
06/25/1997EP0696199A4 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
06/25/1997EP0636141B1 Pyrimidinyl acetamides as elastase inhibitors
06/25/1997CN1152910A Difluorostatone antiviral agents
06/25/1997CN1152881A Technetium-99m labeled imaging agents
06/24/1997US5641880 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
06/24/1997US5641862 General method for producing and selecting peptides with specific properties
06/24/1997US5641861 μopioid receptor ligands: agonists and antagonists
06/24/1997US5641752 Methods of using endothelin antagonists
06/19/1997WO1997021804A1 Novel thermolysin-like protease and use thereof
06/19/1997WO1997021728A1 PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
06/19/1997WO1997021726A1 Agents for promoting bone formation
06/19/1997WO1997021725A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
06/19/1997DE19546938A1 New carbamoyl substituted piperidine carbonyl peptide derivatives
06/19/1997CA2239908A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
06/19/1997CA2236335A1 Agents for promoting bone formation
06/18/1997EP0779296A2 D-alpha-aminoalkanoyl-(S)-N-alpha-alkylbenzyl amides useful as intermediates for artificial sweeteners
06/18/1997EP0779076A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it
06/18/1997CN1035183C Process for preparation of alpha-L-aspartyl-L-phenylalanine methyl ester hydrochloride
06/18/1997CN1035157C Process and apparatus for recovery of raw materials in the aspartame preparation process
06/17/1997US5639885 Sustained delivery of pharmacologically active peptides to brain
06/17/1997US5639860 Endothelin-antagonizing peptide
06/17/1997US5639859 Carboxylate protective groups, a process for their preparation, their coupling to a functional group, and their use
06/17/1997US5639783 Ketone derivatives
06/17/1997US5639781 Alcohol or aldehyde derivatives and their use
06/17/1997US5639745 Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
06/17/1997US5639739 Useful for treating thrombosis in mammals by inhibiting trypsin-like serine protease enzymes
06/17/1997US5639732 Phosphorous-containing cysteine and serine protease inhibitors
06/17/1997US5639729 Tripeptides useful in immune and CNS therapy
06/12/1997WO1997020856A1 ACYLATED ENOL DERIVATIVES OF α-KETOESTERS AND α-KETOAMIDES
06/11/1997EP0778285A1 The preparation of protected amines or alkylated amino acids
06/11/1997EP0777746A1 Assay for the detection of proteases
06/11/1997EP0777683A1 Antiprotozoal cyclic tetrapeptides
06/11/1997EP0777682A1 New opioid peptide antagonists
06/11/1997EP0777681A2 Cyclic cs-1 peptidomimetics, compositions and methods of using the same
06/11/1997EP0777680A1 Urokinase receptor ligands
06/11/1997EP0777679A1 Delivery of nucleic acids
06/11/1997EP0723442A4 Lactone compounds for treating patients with precancerous lesions
06/11/1997CN1151701A Cascade-polymer complexes and method of producing the same
06/11/1997CN1151700A Tri-, tetra-, penta- and polypeptides and their therapeutic use as an antidepressant agent
06/10/1997US5637754 Crystallization of α-L-aspartyl-L-phenylalanine methyl ester from aqueous solution
06/10/1997US5637698 Fused multiple ring lactams
06/10/1997US5637616 Method for treating diseases mediated by proteases
06/10/1997US5637602 Nervous system disorders; gastrointestinal disorders
06/10/1997US5637599 Arginine mimic derivatives as enzyme inhibitors
06/10/1997US5637565 Cocrystallization of different streptogramins
06/10/1997US5637564 Hydrophilic part derived from sugar, polyol, aminopolyol; hydrophobic part derived from hydrocarbon, linked to hydrophilic part by junction bearing amino acid
06/10/1997US5637459 Systematic evolution of ligands by exponential enrichment: chimeric selex
06/05/1997WO1997019953A2 New lh-rh antagonists with improved effectiveness